US Patent Issued to BeyondSpring Pharmaceuticals on Oct. 7 for "Composition and method for reducing neutropenia" (New York Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,886, issued on Oct. 7, was assigned to BeyondSpring Pharmaceuticals Inc. (New York).

"Composition and method for reducing neutropenia" was invented by Lan Huang (New York), George Kenneth Lloyd (New York) and Ramon Mohanlal (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of reducing neutropenia that is caused by chemotherapy or radiation therapy by administering plinabulin to a subject."

The patent was filed on Jan. 21, 2022, under Application No. 17/581,174.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fne...